Amphastar Pharma (AMPH) Misses Q1 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. RELIANCE:I
2. LYB
3. BP
4. REGN
5. LITE
6. CL
7. OKTA
8. NWG
9. NWG:LN
10. PERI

Go back to Amphastar Pharma (AMPH) Misses Q1 EPS by 3c

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2018

May 9, 2018 4:05 PM EDT

Reports Net Revenues of $58.4 Million for the Three Months Ended March 31, 2018

RANCHO CUCAMONGA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended March 31, 2018.

First Quarter Highlights

Net revenues of $58.4 million for the first quarterGAAP net loss of $7.2 million, or $0.16 per share, for the first quarterAdjusted non-GAAP net loss of $2.5 million, or $0.05 per share, for the first quarter

Dr. Jack Zhang, Amphastars CEO, commented:  We are pleased to announce that we have... More